dapsone has been researched along with Graft vs Host Disease in 3 studies
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "International guidelines for Pneumocystis jirovecii pneumonia (PJP) prevention recommend prophylaxis for ≥6 months following allogeneic hematopoietic cell transplantation, and longer in patients with graft-versus-host disease (GVHD) or on immunosuppressive therapy (IST)." | 1.56 | High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era. ( Chaudhry, A; Dabas, R; Daly, A; Dharmani-Khan, P; Dowhan, M; Duggan, P; Evernden, C; Gregson, D; Jamani, K; Jimenez-Zepeda, V; Johnson, A; Jupp, J; Kalra, A; Khan, F; Storek, J; Tay, J, 2020) |
| " Dapsone prophylaxis at this dosage is associated with significantly higher rates of PCP than is TMP-SMZ after allogeneic marrow transplantation." | 1.30 | High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. ( Boeckh, M; Crawford, SW; Flowers, ME; Gooley, TA; Souza, JP, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Evernden, C | 1 |
| Dowhan, M | 1 |
| Dabas, R | 1 |
| Chaudhry, A | 1 |
| Kalra, A | 1 |
| Dharmani-Khan, P | 1 |
| Gregson, D | 1 |
| Johnson, A | 1 |
| Jupp, J | 1 |
| Jimenez-Zepeda, V | 1 |
| Jamani, K | 1 |
| Duggan, P | 1 |
| Tay, J | 1 |
| Khan, F | 1 |
| Daly, A | 1 |
| Storek, J | 1 |
| Souza, JP | 1 |
| Boeckh, M | 1 |
| Gooley, TA | 1 |
| Flowers, ME | 1 |
| Crawford, SW | 1 |
| Vasconcelles, MJ | 1 |
| Bernardo, MV | 1 |
| King, C | 1 |
| Weller, EA | 1 |
| Antin, JH | 1 |
1 trial available for dapsone and Graft vs Host Disease
| Article | Year |
|---|---|
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Antifungal Agents; Bone Ma | 2000 |
2 other studies available for dapsone and Graft vs Host Disease
| Article | Year |
|---|---|
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antilymphocyte Serum; Atovaquone; CD4 Lymphocyte Cou | 2020 |
High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis.
Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Clinical Trials as Topic; Cohort Studies; | 1999 |